Humacyte, Inc. (HUMA)

NasdaqGS • Currently up 0.05 (+13.13%) in today's trading session

1 member of Congress has disclosed 10 trades in Humacyte, Inc. (HUMA) via STOCK Act filings. The most recent disclosure was a sale by Tommy Tuberville on 3 May 2024. Aggregate disclosed activity totals roughly $48.5K in sales (midpoint estimates from bracketed disclosure amounts).

Humacyte, Inc. is currently trading at $0.45, positioned at 9% of its 52-week range ($0.34 – $1.52).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$0.45
24h Change
+0.05 (+13.13%)
52 Week Range
$0.34–$1.52
View on NASDAQ

Humacyte, Inc. Price History and Technical Analysis

Congressional Trading Activity for HUMA

Select to highlight on chart
5 transactions
Compliance: 0%
Tommy Tuberville3 May 20245 Aug 2026SaleStock$1,001 - $15,000N/A
Tommy Tuberville3 May 20245 Aug 2026SaleStock$15,001 - $50,000N/A
Tommy Tuberville21 Mar 20245 Aug 2026Stock$1,001 - $15,000N/A
Tommy Tuberville21 Mar 202410 Aug 2026Stock$1,001 - $15,000N/A
Tommy Tuberville21 Mar 202410 Aug 2026Stock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$124.51M

Volume

5.16M

Beta

2.68

P/E Ratio

-0.86

Fundamentals

EPS

$-0.52

Div. Yield

-

Open

$0.41

Day Range

$0.40 – $0.45

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Laura E. Niklason
IPO Date
2020-12-01
Website
www.humacyte.com

Humacyte, Inc. focuses on developing and manufacturing readily available, implantable human tissues engineered in a laboratory setting. These bioengineered tissues are designed to treat a wide array of diseases and conditions across various anatomica...

Earnings

Next Report

Q3 2026

10 Nov

EPS Est.

$-0.09

Rev. Est.

$766K

Days Until

1

Recent Quarters

Q2 202612 Aug
EPS$-0.16
Miss 41.0%
Q1 202613 May
EPS$-0.09
Beat 10.0%
Q4 202527 Mar
EPS$-0.13
Beat 0.0%
Q3 202512 Nov
EPS$-0.14
Beat 17.6%
Q2 202511 Aug
EPS$-0.24
Miss 60.0%
Q1 202513 May
EPS$0.28
Beat 247.4%
Q4 202428 Mar
EPS$-0.16
Beat 33.3%
Q3 20248 Nov
EPS$-0.33
Miss 32.0%
Q2 202413 Aug
EPS$-0.48
Miss 108.7%
Q1 202410 May
EPS$-0.29
Miss 31.8%
Q4 202322 Mar
EPS$-0.24
Beat 0.0%
Q3 20239 Nov
EPS$-0.25
Beat 0.0%
Q2 202314 Aug
EPS$-0.22
Beat 0.0%
Q1 202312 May
EPS$-0.36
Miss 63.6%
Q4 202224 Mar
EPS$-0.04
Beat 83.3%
Q3 202210 Nov
EPS$-0.25
Miss 19.1%
Q2 202212 Aug
EPS$0.35
Beat 259.1%
Q1 202213 May
EPS$-0.19
Beat 9.5%
Q4 202129 Mar
EPS$0.41
Beat 315.8%
Q3 202112 Nov
EPS$-0.72
Miss 242.9%
Q2 202116 Aug
EPS$-0.17
Beat 69.6%
Q1 202117 May
EPS$-0.20
Beat 77.8%
Q4 202016 Feb
EPS$-5.61
Q3 202012 Nov
EPS$-1.43
Q1 202030 Jun
EPS$-0.68
Q4 201931 Mar
EPS$-0.81

2 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about HUMA

Which members of Congress have traded HUMA?
1 member of Congress has disclosed 10 trade in Humacyte, Inc. (HUMA) under the STOCK Act: Tommy Tuberville.
When was HUMA most recently disclosed by Congress?
The most recent HUMA disclosure was a sale by Tommy Tuberville on 3 May 2024.
What is the total disclosed congressional trading volume for HUMA?
Members of Congress have disclosed approximately $48.5K in HUMA sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in HUMA?
This HUMA page updates as soon as new STOCK Act disclosures are filed for Humacyte, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.